Healthcare Sales & Marketing Network News: obesity

Searching News Database: obesity

Your search returned too many results! The most recent 500 items are shown below:

HSMN NewsFeed - 11 Aug 2021
Ethicon's Echelon Circular Powered Stapler Associated With Major Reduction In Serious Complications Following Colorectal Surgery
Devices Surgery

HSMN NewsFeed - 9 Aug 2021
Glooko Announces New Chief Technology Officer
Devices Monitoring Endocrinology Personnel

HSMN NewsFeed - 5 Aug 2021
Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led By Sorrento Therapeutics And Including Existing Investors And The Foundation For Prader-Willi Research
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Jul 2021
nanoMesh(TM) LLC (a subsidiary of Exogenesis Corporation) Announces Expansion of the nanoMesh(TM) Product Line Offering to the Clinical Community
Devices Surgery Product Launch

HSMN NewsFeed - 25 Jun 2021
Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jun 2021
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
Devices Surgery Product Launch

HSMN NewsFeed - 6 Apr 2021
nanoMesh(TM) LLC (a subsidiary of Exogenesis Corporation) Announces Completion Filing of a Second Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA)
Devices Surgery FDA

HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Dec 2020
CHMP Recommends the Approvals of RINVOQ(TM) (Upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Nov 2020
Elevian Announces $15 Million Equity Financing
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 16 Oct 2020
Akero Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for Efruxifermin (EFX) in NASH
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Aug 2020
Qualigen Therapeutics Appoints Amy Broidrick to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 12 May 2020
Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 18 Nov 2019
Levo Therapeutics Receives Fast Track Designation From FDA for Intranasal Carbetocin for the Treatment of Prader-Willi Syndrome
Biopharmaceuticals Neurology Drug Delivery FDA

HSMN NewsFeed - 7 Oct 2019
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
Devices Venture Capital

HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Apr 2019
ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products
Devices Wound Care Distribution

HSMN NewsFeed - 11 Mar 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Mar 2019
Ampio Updates Regulatory Status for Ampion
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jan 2019
Dr. Jan M. Lundberg, Former Head of R&D at AstraZeneca and Eli Lilly has Joined Betagenon's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Dec 2018
Ampio Updates Regulatory Status for Ampion
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Dec 2018
Panther Orthopedics Announces Successful Clinical Use of the PUMA System (TM)
Devices Orthopaedic

HSMN NewsFeed - 30 Oct 2018
G3 Pharmaceuticals Signs Exclusive License and Option Agreement for Treating Diastolic Heart Failure (HFpEF) by Inhibiting Galectin-3
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 4 Oct 2018
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
Devices Dermatology FDA

HSMN NewsFeed - 4 Sep 2018
Applied Therapeutics Announces Appointment of Riccardo Perfetti, MD, PhD, as Chief Medical Officer
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 30 Jul 2018
ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer
Devices Oncology Personnel

HSMN NewsFeed - 17 Jul 2018
BAROnova Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the TransPyloric Shuttle(R) (TPS(R)) Device Intended for the Treatment of Obesity
Devices FDA

HSMN NewsFeed - 27 Jun 2018
Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis
Biopharmaceuticals FDA

HSMN NewsFeed - 10 May 2018
Permira Funds To Acquire Corin A Leading Orthopaedic Company
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 10 May 2018
ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada
Devices Regulatory

HSMN NewsFeed - 23 Apr 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Biopharmaceuticals

HSMN NewsFeed - 13 Apr 2018
Ampio Updates Regulatory, Clinical and NYSE Activities
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
Biopharmaceuticals Endocrinology Cardiology FDA

HSMN NewsFeed - 6 Mar 2018
FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
Diagnostics Oncology FDA

HSMN NewsFeed - 19 Feb 2018
Blockchain Based Medical Device from NnBU Set to Raise �15million in ICO
Devices Venture Capital

HSMN NewsFeed - 14 Feb 2018
Galmed Announces ARRIVE Study Data
Biopharmaceuticals

HSMN NewsFeed - 8 Feb 2018
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
Biopharmaceuticals Product Launch

HSMN NewsFeed - 24 Jan 2018
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2018
Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
Biopharmaceuticals Endocrinology Product Launch

HSMN NewsFeed - 9 Jan 2018
New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
Devices Surgery Product Launch

HSMN NewsFeed - 3 Jan 2018
H2-Pharma and CHEPLAPHARM Announce Re-Launch of XENICAL(R) Capsules
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 26 Dec 2017
FDA Grants INSYS Therapeutics �Fast Track� Designation for Cannabidiol (CBD) Oral Solution as Investigational Treatment for Prader-Willi Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Dec 2017
Allergan Receives FDA Clearance For the CoolSculpting(R) Treatment To Improve Appearance Of Lax Tissue In The Double Chin
Devices Dermatology FDA

HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology

HSMN NewsFeed - 30 Nov 2017
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
Devices Endocrinology Personnel

HSMN NewsFeed - 27 Nov 2017
FDA Clearance For Perspectum Diagnostics' LiverMultiScan(TM) Means More Patients Can Benefit From Access To State-Of-The-Art Non-Invasive Diagnostic Aid For Liver Disorders
Diagnostics Radiology FDA

HSMN NewsFeed - 27 Nov 2017
Pharming Submits Supplemental Biologics License Application to FDA for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Nov 2017
Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 15 Nov 2017
Noden Pharma Announces FDA Approval of Tekturna(R) (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 13 Nov 2017
EMD Serono Receives FDA Approval for New GONAL-f(R) RFF Redi-ject(R) Pen
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 20 Oct 2017
Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States
Devices Surgery

HSMN NewsFeed - 3 Oct 2017
EnteroMedics Announces Acquisition Of ReShape Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 21 Aug 2017
Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
Devices Surgery Product Launch

HSMN NewsFeed - 7 Aug 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Cheplapharm Arzneimittel GmbH for Mysimba(TM) in Germany, France and Austria
Biopharmaceuticals Distribution

HSMN NewsFeed - 1 Aug 2017
Rhythm Expands Executive Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2017
EnteroMedics Announces First Veterans Choice Program vBloc(R) Implant for Obesity at Methodist Dallas Medical Center
Devices

HSMN NewsFeed - 11 Jul 2017
Enterome and Nestl� Health Science Launch New Diagnostics Company
Diagnostics

HSMN NewsFeed - 23 Jun 2017
EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for the First-Line Treatment of Advanced Renal Cell Carcinoma in Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 21 Jun 2017
EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
Devices

HSMN NewsFeed - 6 Jun 2017
Ethicon Announces FDA Approval For SURGICEL(R) Powder Absorbable Hemostat
Devices Surgery FDA

HSMN NewsFeed - 31 May 2017
EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook
Devices Neurology

HSMN NewsFeed - 24 May 2017
DERMABOND(R) PRINEO(R) Skin Closure System May Improve Outcomes and Lower Hospital Costs
Devices Surgery

HSMN NewsFeed - 18 May 2017
EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center
Devices Neurology

HSMN NewsFeed - 15 May 2017
BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 May 2017
Rhythm Receives Expanded FDA Breakthrough Therapy Designation for Setmelanotide for Rare Genetic Disorders of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 5 May 2017
New ECHELON FLEX(TM) GST System (45mm) Delivers Benefits of Precision Stapling Performance to Thoracic and Colorectal Procedures
Devices Surgery Product Launch

HSMN NewsFeed - 2 May 2017
Medeon Biodesign Announces Approval to Begin CE Clinical Study for the XPro(TM) Large Bore Vascular Closure System
Devices Interventional Regulatory

HSMN NewsFeed - 2 May 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Navamedic ASA for Mysimba(R) (naltrexone HCl / bupropion HCl prolonged release) in Five Nordic Countries
Biopharmaceuticals Distribution

HSMN NewsFeed - 1 May 2017
Ampio Initiates Pivotal Trial of Ampion(TM)
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 24 Apr 2017
SIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
Devices Oncology

HSMN NewsFeed - 20 Apr 2017
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
Devices Orthopaedic FDA

HSMN NewsFeed - 19 Apr 2017
Ethicon Announces 510(k) Clearance For ECHELON CIRCULAR(TM) Powered Stapler
Devices Surgery FDA

HSMN NewsFeed - 19 Apr 2017
USGI Medical Appoints Carlos Babini as President and Chief Executive Officer
Devices Gastroenterology Personnel

HSMN NewsFeed - 18 Apr 2017
Eiger Announces Industry Veteran Lisa Porter, M.D. to Lead Development of Exendin 9-39 for the Treatment of Post-Bariatric Hypoglycemia
Biopharmaceuticals Gastroenterology Surgery Personnel

HSMN NewsFeed - 18 Apr 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Biopharmaceuticals

HSMN NewsFeed - 28 Mar 2017
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
Diagnostics Gastroenterology Product Launch

HSMN NewsFeed - 15 Mar 2017
Julie G. Anderson Joins BioVie as Independent Director and Investor
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2017
Ethicon Launches ENSEAL(R) X1 Large Jaw Tissue Sealer, Establishing Next Generation Of Advanced Bipolar Devices
Devices Surgery Product Launch

HSMN NewsFeed - 10 Feb 2017
FDA Approves EMFLAZA(TM) (deflazacort) Tablets and Oral Suspension for the Treatment of Duchenne Muscular Dystrophy in Patients 5 Years and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Feb 2017
Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda(TM)
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 17 Jan 2017
Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer
Devices Surgery Personnel

HSMN NewsFeed - 10 Jan 2017
PENTAX Medical Expands Interventional Endoscopy Offering with Acquisition of C2 Therapeutics
Devices Mergers & Acquisitions

HSMN NewsFeed - 5 Jan 2017
Eisai Acquires All Global Development And Marketing Rights For Chronic Weight Management Treatment Lorcaserin HCI
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 14 Dec 2016
Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Dec 2016
Pharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST(R) From Valeant
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 7 Dec 2016
Gordian Surgical Completes $2.25 Million Raise and Receives FDA Clearance for TroClose1200(TM)
Devices Surgery FDA Venture Capital

HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution

HSMN NewsFeed - 4 Nov 2016
ReShape Medical, Inc. Unveils US Commercial Data Demonstrating Increased Weight Loss with ReShape(R) Dual Balloon
Devices Gastroenterology

HSMN NewsFeed - 27 Sep 2016
EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors
Devices Neurology Gastroenterology Personnel

HSMN NewsFeed - 20 Sep 2016
Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH
Biopharmaceuticals Gastroenterology Mergers & Acquisitions

HSMN NewsFeed - 20 Sep 2016
KVK Tech Announces FDA-Approval of Lomaira(TM) (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily for Weight Reduction
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Sep 2016
Medeon Biodesign Receives FDA 510(k) Clearance for Abclose(TM) - Laparoscopic Port Site Closure Device
Devices Surgery FDA

HSMN NewsFeed - 13 Sep 2016
vBloc Institute Demonstrates Positive Clinical Success in Patients Struggling with Weight Loss as Compared to Pivotal FDA Trial with EnteroMedics vBloc(R) Therapy in Combination with vBloc(R) Achieve Program
Devices Neurology

HSMN NewsFeed - 12 Sep 2016
Obalon Announces FDA Approval of Obalon Balloon System
Devices Gastroenterology FDA

HSMN NewsFeed - 9 Sep 2016
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Sep 2016
Galmed Pharmaceuticals Announces the Appointment of Dr. Liat Hayardeny, Ph.D. MBA, as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2016
Marinus Appoints Seth H.Z. Fischer to its Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 22 Aug 2016
Ethicon Establishes Unmatched Knotless Suture Portfolio With Launch Of STRATAFIX(TM) Spiral Plus Devices
Devices Surgery Product Launch

HSMN NewsFeed - 8 Aug 2016
ReShape Medical(R) Announces the Appointment of Michael J. Mangano as President and Chief Executive Officer
Devices Gastroenterology Personnel

HSMN NewsFeed - 2 Aug 2016
pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
Devices Drug Delivery Orthopaedic

HSMN NewsFeed - 1 Aug 2016
Orexigen Completes Acquisition of All U.S. Rights to Contrave(R) and Launches U.S. Sales Organization
Biopharmaceuticals Acquisitions Product Launch

HSMN NewsFeed - 28 Jul 2016
FDA Clears Expanded Indication for Itamar Medical's WatchPAT(TM) Sleep Apnea Diagnostic Device for Adolescents
Devices Diagnostics FDA

HSMN NewsFeed - 25 Jul 2016
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
Devices Regenerative Medicine Product Launch

HSMN NewsFeed - 22 Jul 2016
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 30 Jun 2016
OPKO Health to Acquire Transition Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Jun 2016
EnteroMedics Highlights Recent Patient Success with vBloc(R) Therapy in Combination with vBloc(R) Achieve Program
Devices

HSMN NewsFeed - 29 Jun 2016
FDA Advisory Committee recommends approval of Jardiance(R) (empagliflozin) for cardiovascular indication in 12-11 vote
Biopharmaceuticals Endocrinology Cardiology FDA

HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 1 Jun 2016
EnteroMedics Announces First-of-its-Kind Procedure with vBloc(R) Therapy Used as Adjunctive Rescue Treatment for Failed Gastric Sleeve in Patients with Obesity
Devices

HSMN NewsFeed - 6 May 2016
Application of Fish Skin to Open Wounds Improves Healing
Regenerative Medicine Wound Care

HSMN NewsFeed - 3 May 2016
EnteroMedics Announces Closing of $6.25 Million Third Tranche of Previously-Announced Convertible Notes Offering
Devices Venture Capital

HSMN NewsFeed - 2 May 2016
EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy Medical to Provide vBloc(R) Neurometabolic Therapy to US Department of Veterans Affairs Medical Facilities
Devices Distribution

HSMN NewsFeed - 20 Apr 2016
Enterome Raises EUR14.5 Million in Series C Financing Round
Biopharmaceuticals Gastroenterology Venture Capital

HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 3 Feb 2016
ProtoStar(TM) Announces the LifeWalker(TM) Upright, a New Medical Walker Designed to Enable Users to Stand Upright and Walk Safer and Longer for Improved Health
Devices Product Launch

HSMN NewsFeed - 1 Feb 2016
New Company ProtoStar(TM) Launched to Produce Safer, Next-Generation Assistive Mobility Products Designed to Reduce Fall Risk and Enable Users to Stand Upright and Walk Longer
Devices

HSMN NewsFeed - 26 Jan 2016
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
Biopharmaceuticals Endocrinology Product Launch

HSMN NewsFeed - 13 Jan 2016
EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering
Devices Neurology Venture Capital

HSMN NewsFeed - 6 Jan 2016
Ivenix, Inc. Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 5 Jan 2016
Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 18 Dec 2015
Gelesis Closes $31.5 Million Growth Financing
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 16 Dec 2015
Rhythm Appoints David Meeker, MD, and David McGirr to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Nov 2015
AMNIOX Highlights Study Showing Eighty Percent of Patients With Lower-extremity Ulcers Achieve Healing When Treated with NEOX(R) Wound Allograft
Devices Wound Care

HSMN NewsFeed - 4 Nov 2015
Vaccinogen Promotes Peter Morsing, Ph.D. to Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Nov 2015
EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer
Devices Gastroenterology Personnel

HSMN NewsFeed - 28 Sep 2015
Zafgen Announces Transition of Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Aug 2015
FDA Approves Dexcom G5(R) Mobile Continuous Glucose Monitoring System
Devices Monitoring Endocrinology FDA

HSMN NewsFeed - 11 Aug 2015
FDA Approves Orbera(TM) Bariatric System
Devices Gastroenterology Surgery FDA

HSMN NewsFeed - 5 Aug 2015
Metacrine Raises $36 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 27 May 2015
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 May 2015
EnteroMedics Announces First US Commercial Implant of vBloc(R) Neurometabolic Therapy System at Tufts Medical Center in Boston, Massachusetts
Devices

HSMN NewsFeed - 20 Apr 2015
Cardiovascular Systems Receives FDA Clearance for New Peripheral Diamondback Device
Devices Interventional FDA

HSMN NewsFeed - 6 Apr 2015
FDA Expands Indication for EVARREST(R) Fibrin Sealant Patch
Devices Surgery FDA

HSMN NewsFeed - 2 Apr 2015
Ethicon�s HARMONIC FOCUS(R)+ Shears Now Proven to Produce Vessel Seal Strength Equivalent to Advanced Bipolar Devices
Devices Surgery

HSMN NewsFeed - 17 Feb 2015
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
Regenerative Medicine Orthopaedic Personnel

HSMN NewsFeed - 12 Nov 2014
Beverly Huss Joins Surefire Medical Board of Directors
Devices Interventional Oncology Drug Delivery Personnel

HSMN NewsFeed - 5 Nov 2014
U.S. Veterans And Military Gain Access To "Smart" Wound Care Technology
Devices Wound Care Distribution

HSMN NewsFeed - 3 Nov 2014
Salix and Pharming Announce the Launch of RUCONEST(R) in the U.S. for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
Biopharmaceuticals Product Launch

HSMN NewsFeed - 27 Oct 2014
Zogenix Acquires U.K.-Based Brabant Pharma
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 29 Jul 2014
Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jul 2014
Salix and Pharming Announce FDA Approval of RUCONEST(R) for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Jul 2014
MYOS Corporation Appoints World Renowned Scientific Visionary and Entrepreneur, J. Craig Venter, Ph.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2014
Transition Therapeutics Appoints Carl Damiani as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2014
Cardiovascular Systems Announces Plans for New Corporate Headquarters
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2014
TERUMO(R) Launches Expanded GLIDEWAY(TM) Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures
Devices Interventional Urology Product Launch

HSMN NewsFeed - 6 May 2014
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
Biopharmaceuticals FDA

HSMN NewsFeed - 1 May 2014
Enterome Raises �10 million in Series B Fund Raising
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Apr 2014
EnteroMedics Inc. Appoints Mark Bullivant as Vice President of Marketing
Devices Personnel

HSMN NewsFeed - 7 Apr 2014
EndoBarrier(R) Therapy Receives Reimbursement Coverage in Israel
Devices Reimbursement

HSMN NewsFeed - 2 Apr 2014
Ablative Solutions Receives FDA Clearance for the Peregrine System(TM) Infusion Catheter
Devices FDA

HSMN NewsFeed - 12 Mar 2014
Cardiovascular Systems Announces First Peripheral Arterial Disease Case Treated with New, Low-Profile, 60cm Diamondback Peripheral System
Devices Interventional

HSMN NewsFeed - 11 Mar 2014
Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 10 Mar 2014
Cardiovascular Systems Receives FDA Clearance for Low Profile, 60cm Diamondback Devices Designed to Expand the Treatment of Peripheral Artery Disease (PAD)
Devices Interventional FDA

HSMN NewsFeed - 5 Mar 2014
Independent Study Shows V.A.C. VeraFlo(TM) Therapy More Beneficial Than Traditional V.A.C.(R) Therapy
Devices Wound Care

HSMN NewsFeed - 3 Mar 2014
BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
Regenerative Medicine Personnel

HSMN NewsFeed - 3 Mar 2014
U.S. FDA Approves Bydureon(R) Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Drug Delivery Endocrinology FDA

HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jan 2014
Synthetic Biologics Strengthens Clinical & Regulatory Team to Support Expanding Pipeline of Infectious Disease Programs
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 3 Jan 2014
Metabolon Closes $15 Million Series E Financing
Diagnostics Venture Capital Personnel

HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 12 Dec 2013
VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Dec 2013
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
Devices Surgery FDA

HSMN NewsFeed - 21 Nov 2013
Thomas J. Fogarty, M.D. Joins SinuSys(TM) Corp. Board of Directors
Devices Venture Capital Personnel

HSMN NewsFeed - 21 Nov 2013
Ethicon Announces Collaboration Agreement with MEGADYNE(R)
Devices Surgery Distribution

HSMN NewsFeed - 11 Nov 2013
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
Devices Surgery Product Launch

HSMN NewsFeed - 29 Oct 2013
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
Devices FDA

HSMN NewsFeed - 28 Oct 2013
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
Devices Surgery FDA

HSMN NewsFeed - 23 Oct 2013
FDA Approves JUV�DERM VOLUMA(TM) XC
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 9 Oct 2013
USGI Medical Receives FDA Approval to Launch Head-to-Head Pivotal Study to Determine Safety, Effectiveness of Incisionless, Endoscopic Weight Loss Procedure
Devices Surgery FDA

HSMN NewsFeed - 30 Sep 2013
Alkermes Expands Senior Management Team
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 24 Sep 2013
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries
Devices Interventional FDA

HSMN NewsFeed - 24 Sep 2013
EnteroMedics on Track for Approval Decision in First Half of 2014 Following Formal Response to Premarket Approval Application From FDA
Devices FDA

HSMN NewsFeed - 19 Sep 2013
Arrowhead Promotes David Lewis to Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Sep 2013
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
Devices Drug Delivery Oncology

HSMN NewsFeed - 3 Sep 2013
Healogics and The Ohio State University Renew Partnership
Wound Care

HSMN NewsFeed - 8 Aug 2013
Hologic Launches New Bone Densitometer Platform for Osteoporosis, Cardiovascular Disease, and Obesity Assessment
Devices Radiology Product Launch

HSMN NewsFeed - 26 Jul 2013
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 17 Jul 2013
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 9 Jul 2013
VIVUS Announces Avanafil Partnership With Menarini
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Jun 2013
VIVUS Announces SPEDRA (avanafil) Approval in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Jun 2013
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza(R) (saxagliptin)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 17 Jun 2013
NGM Biopharmaceuticals and MedImmune, AstraZeneca's Biologics Arm, Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 7 Jun 2013
Eisai Announces Availability of BELVIQ(R) (lorcaserin HCl) CIV Tablets for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Biopharmaceuticals

HSMN NewsFeed - 6 May 2013
Arrowhead Closes $36 Million Private Offering
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 May 2013
New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 2 Apr 2013
Apollo Endosurgery's OverStitch(TM) Endoscopic Suturing Platform Launches in Europe
Devices Surgery Regulatory Product Launch

HSMN NewsFeed - 20 Mar 2013
Ethicon Receives 510(K) Clearance for ENSEAL(R) G2 Cordless
Devices Surgery FDA

HSMN NewsFeed - 6 Mar 2013
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
Devices Distribution

HSMN NewsFeed - 20 Feb 2013
FDA Approves Natrelle(R) 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
Devices FDA

HSMN NewsFeed - 20 Feb 2013
EnteroMedics Names Greg S. Lea Chief Operating Officer
Devices Personnel

HSMN NewsFeed - 14 Feb 2013
Elcelyx Therapeutics Completes $20 Million Series C Financing to Advance NewMet and Lovidia
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 5 Feb 2013
Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 4 Feb 2013
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
Devices Surgery FDA

HSMN NewsFeed - 22 Jan 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 22 Jan 2013
SafeStitch Medical(R) Announces Encouraging Result of Transluminal Procedure to Correct GERD and Obesity with Two Years Follow Up
Devices Gastroenterology

HSMN NewsFeed - 4 Dec 2012
Zafgen Secures $21 Million in Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Nov 2012
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Nov 2012
Allergan, Inc. to Acquire SkinMedica, Inc.
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 15 Oct 2012
Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 4 Oct 2012
Ethicon Announces Launch of STRATAFIX(TM) Knotless Tissue Control Devices
Devices Surgery

HSMN NewsFeed - 1 Oct 2012
SafeStitch Medical(R), Inc. Announces Sales of the AMID(TM) Hernia Fixation Device
Devices Surgery

HSMN NewsFeed - 28 Sep 2012
Ethicon Introduces Next Innovation in Line of Powered Endocutters; 45mm Design Allows Surgeons Stability and Control Near Vital Structures
Devices Surgery

HSMN NewsFeed - 21 Sep 2012
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Jul 2012
Neurotech(R) Launches Neurotech Recovery - Back, a New Device to Treat Low Back Pain
Devices Orthopaedic

HSMN NewsFeed - 2 Jul 2012
NeuroSigma Receives Global Quality Control Certification
Devices Regulatory

HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 6 Jun 2012
Beacon Endoscopic Announces Commercial Launch of BNX(TM) System for Use in Endoscopic Ultrasound Procedures
Devices

HSMN NewsFeed - 18 May 2012
ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea
Devices FDA

HSMN NewsFeed - 16 May 2012
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
Devices Interventional Neurology Acquisitions

HSMN NewsFeed - 27 Apr 2012
Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Apr 2012
VIVUS Appoints Ernest Mario, Ph.D. to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2012
Sequana Medical�s ALFApump(R) System Proves to Be a Safe and Efficacious Breakthrough Technology in Ascites Management
Devices

HSMN NewsFeed - 19 Apr 2012
GI Dynamics Announces First Cases of EndoBarrier(R) Therapy in Australia
Devices Gastroenterology

HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 9 Apr 2012
NeuroSigma Awarded NIH Grant for Further Development of Its Thin-Film Nitinol Covered Neurovascular Stent
Devices Neurology Interventional

HSMN NewsFeed - 2 Apr 2012
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
Devices Neurology Personnel

HSMN NewsFeed - 27 Mar 2012
VIVUS Announced Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Mar 2012
BYETTA(R) Approved for Use with Basal Insulin in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 21 Mar 2012
UCLA Professor of Neurosurgery and NeuroSigma Co-Founder Honored for Groundbreaking Work including Deep Brain Stimulation for Treatment of PTSD
Devices Neurosurgery Personnel

HSMN NewsFeed - 2 Mar 2012
Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Mar 2012
Sequana Medical's ALFApump(R) System Receives Reimbursement in Germany for Breakthrough Technology in Ascites Management
Devices Regulatory Reimbursement

HSMN NewsFeed - 23 Feb 2012
ULURU Inc. Announces Approval to Market Altrazeal(R) in Australia
Biopharmaceuticals Wound Care Regulatory

HSMN NewsFeed - 7 Feb 2012
Lyndon B. Johnson General Hospital First to use PICO* Single Use Negative Pressure Wound Therapy System from Smith & Nephew
Devices Wound Care

HSMN NewsFeed - 19 Jan 2012
Bristol-Myers Squibb and AstraZeneca Receive Complete Response Letter from U.S. Food and Drug Administration for Dapagliflozin
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 23 Dec 2011
Allergan Reassures Patients and Surgeons of the Quality and Safety of Its Breast Implant Devices Sold and Distributed Worldwide
Devices

HSMN NewsFeed - 23 Dec 2011
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
Biopharmaceuticals

HSMN NewsFeed - 13 Dec 2011
Baxter Signs Definitive Agreement to Acquire Synovis
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 13 Dec 2011
EnteroMedics Receives First Approval for the Active Implantable Medical Device Components of the Maestro System From Australian Therapeutic Goods Administration (TGA)
Devices Regulatory

HSMN NewsFeed - 8 Nov 2011
Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin
Biopharmaceuticals

HSMN NewsFeed - 4 Nov 2011
The Medical University of Vienna and Vienna General Hospital Perform the First two Commercial Implants Worldwide of Sequana Medical's ALFApump(R) System
Devices

HSMN NewsFeed - 27 Oct 2011
Arrowhead Research Appoints Bruce Given M.D. Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2011
National Healing Corporation and Diversified Clinical Services to Merge
Devices Wound Care Mergers & Acquisitions

HSMN NewsFeed - 2 Sep 2011
EnteroMedics Announces Presentation of Maestro(R) RC System Clinical Data at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders
Devices Surgery

HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Aug 2011
Daiichi Sankyo, Inc. Appoints Executive Vice President of Drug Development for the Americas
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Aug 2011
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 25 Jul 2011
Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 18 Jul 2011
NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
Devices Interventional Licensing

HSMN NewsFeed - 13 Jul 2011
Sequana Medical Receives CE Mark Approval for the ALFApump System and Adds Key Executive to Team
Devices Personnel

HSMN NewsFeed - 7 Jul 2011
Zafgen Secures $33 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Jun 2011
Nimbus Discovery Secures $24 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 21 Jun 2011
Bydureon Receives Marketing Authorization in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 2 Jun 2011
Healthpoint Biotherapeutics Acquires Regranex(R) Gel
Biopharmaceuticals Wound Care Acquisitions

HSMN NewsFeed - 25 May 2011
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
Biopharmaceuticals Urology Oncology

HSMN NewsFeed - 16 May 2011
Amylin Pharmaceuticals Files Suit Against Eli Lilly
Biopharmaceuticals Litigation

HSMN NewsFeed - 10 May 2011
MR Knee Coil for the Toshiba Vantage Titan Enables Better Clinical Accuracy for Bariatric Imaging
Devices Radiology

HSMN NewsFeed - 27 Apr 2011
Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 25 Apr 2011
NeuroSigma Provides Update on Trigeminal Nerve Stimulation (TNS) - the USB Port to the Brain
Devices Neurology

HSMN NewsFeed - 15 Apr 2011
BYDUREON Recommended for Approval in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 11 Apr 2011
Hansen Medical Submits 510(k) Application With U.S. FDA for Vascular Robotic System and Catheter
Devices Interventional FDA

HSMN NewsFeed - 4 Apr 2011
Orexigen(R) Therapeutics Presents Additional Contrave(R) Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring
Biopharmaceuticals

HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Initiates Pivotal Phase III EVOLVE Trial for Epanova in Patients with Very High Triglycerides
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2011
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
Biopharmaceuticals

HSMN NewsFeed - 17 Feb 2011
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Feb 2011
Versartis Completes $21 Million Series B Financing
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 1 Feb 2011
FDA Issues Complete Response to New Drug Application for Contrave(R) for the Management of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jan 2011
VIVUS Provides Regulatory Update on QNEXA NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Dec 2010
Corcept Therapeutics Announces Positive Phase 3 Study Results for CORLUX for the Treatment of Cushing's Syndrome
Biopharmaceuticals

HSMN NewsFeed - 20 Dec 2010
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
Biopharmaceuticals

HSMN NewsFeed - 8 Dec 2010
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Dec 2010
Orexigen(R) Therapeutics' Investigational Drug Contrave(R) Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Dec 2010
Florida Surgeon Completes World�S First Gastric Band with Spider(R) System
Devices Surgery

HSMN NewsFeed - 10 Nov 2010
Satiety�s TOGA(R) System Named a Top Medical Innovation by Cleveland Clinic Experts
Devices Gastroenterology

HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Oct 2010
Nicholas L. Teti, Jr. Appointed President and CEO of Suneva Medical
Devices Personnel

HSMN NewsFeed - 15 Oct 2010
GI Dynamics Receives European CE Mark Approval for 12 Months of EndoBarrier(TM) Treatment of Type 2 Diabetes and Obesity; Announces U.K. Launch
Devices Gastroenterology Endocrinology Regulatory

HSMN NewsFeed - 5 Oct 2010
NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2010
Hansen Medical Announces First Patients Successfully Treated With New Flexible Catheter Vascular Robotic System
Devices Cardiology

HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Sep 2010
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
Biopharmaceuticals

HSMN NewsFeed - 21 Sep 2010
St. Jude Medical Announces Results from Angio-Seal Evolution Vascular Closure Device Registry Subset Analysis
Devices Interventional

HSMN NewsFeed - 9 Sep 2010
The Benefits of Crospon's EndoFLIP(R) System Presented at International Obesity Surgery Congress 2010
Devices

HSMN NewsFeed - 8 Sep 2010
Rhythm Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Sep 2010
Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Sep 2010
GI Dynamics Announces New Data Showing Significant Weight Loss, Cardiovascular and Metabolic Improvements Following 12 Months of EndoBarrier Treatment
Devices Gastroenterology

HSMN NewsFeed - 1 Sep 2010
GI Dynamics Announces Distribution Agreement with Elemental Healthcare for the EndoBarrier Gastrointestinal Liner
Devices Distribution

HSMN NewsFeed - 31 Aug 2010
Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 30 Aug 2010
EndoGastric Solutions Completes $30 Million Financing Round
Devices Surgery Venture Capital

HSMN NewsFeed - 30 Aug 2010
U.K. Bariatric Surgeon Performs Europe's First ROSE Procedures Using USGI Medical's Incisionless Operating Platform(TM) (IOP)
Devices Surgery

HSMN NewsFeed - 23 Aug 2010
First European Incisionless Procedure to 'Reverse Weight Gain After Gastric Bypass Surgery' Takes Place in UK
Devices

HSMN NewsFeed - 19 Aug 2010
GI Dynamics Announces Key Executive Appointments in Preparation for European Launch of EndoBarrier Gastrointestinal Liner
Devices Gastroenterology Personnel

HSMN NewsFeed - 18 Aug 2010
Euthymics Bioscience, Inc. Appoints Industry Veterans Dr. Pierre Tr�n, Joan Manthis and William Pappafotopoulos to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2010
EnteroMedics Achieves Major Milestones in Global Regulatory and Commercialization Strategy for the Maestro System
Devices Gastroenterology FDA

HSMN NewsFeed - 22 Jul 2010
Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Jul 2010
Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval
Biopharmaceuticals

HSMN NewsFeed - 1 Jul 2010
Eisai Inc. Enters Marketing and Supply Agreement with Arena Pharmaceuticals for Lorcaserin
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2010
MMDI Named Among �Top 50 Companies to Watch� in the Medical Device Industry by Medical Device and Diagnostic Industry Magazine (MD+DI)
Devices Surgery

HSMN NewsFeed - 28 Jun 2010
New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes
Biopharmaceuticals

HSMN NewsFeed - 21 Jun 2010
SURGIMESH Surgical Implants Expands Distribution Coverage Across U.S. as Adoption Increases Significantly and Hernia Mesh Market Grows at Rapid Pace
Devices Surgery Distribution

HSMN NewsFeed - 9 Jun 2010
Astellas Completes Acquisition of OSI Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Jun 2010
Orexigen(R) Therapeutics Announces FDA Acceptance of Contrave(R) New Drug Application for the Treatment of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Jun 2010
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2010
IDEV Technologies Announces European Launch of SUPERA VERITAS(TM) Stent Delivery System
Devices Interventional

HSMN NewsFeed - 13 May 2010
NicOx provides update on FDA Advisory Committee Meeting for naproxcinod
Biopharmaceuticals FDA

HSMN NewsFeed - 10 May 2010
InteKrin Therapeutics Appoints Linda Higgins, PhD as President and Chief Executive Officer. Company Founder Denny Lanfear Named Chairman of the Board.
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2010
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Apr 2010
OSI Pharmaceuticals Announces That Tarceva(R) Received Approval in the European Union for Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Apr 2010
Mylan Begins Marketing First Generic Version of Desoxyn(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 23 Apr 2010
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Apr 2010
Outcomes of Patients Dismissed from the Hospital with Noncardiac Chest Pain
Cardiology

HSMN NewsFeed - 22 Apr 2010
Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
Devices Personnel

HSMN NewsFeed - 19 Apr 2010
Covidien Announces Innovation: Delivered Mobile Surgical Tour
Devices Surgery

HSMN NewsFeed - 26 Mar 2010
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity
Biopharmaceuticals

HSMN NewsFeed - 19 Mar 2010
OSI Pharmaceuticals Announces That Tarceva(R) Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Mar 2010
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Mar 2010
Caron D'Ambruso Joins SafeStitch as Vice President of Sales and Marketing
Devices Surgery Personnel

HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Biopharmaceuticals

HSMN NewsFeed - 8 Mar 2010
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2010
OSI Pharmaceuticals Board of Directors to Review Astellas' Unsolicited Tender Offer
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Mar 2010
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Mar 2010
OSI Pharmaceuticals Confirms Receipt of Unsolicited Proposal From Astellas Pharma
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Mar 2010
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Feb 2010
Arena Pharmaceuticals Receives PDUFA Date for Lorcaserin NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2010
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2010
EnteroMedics Appoints Dr. Scott Shikora as Consulting Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 11 Feb 2010
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 11 Feb 2010
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
Devices

HSMN NewsFeed - 10 Feb 2010
Boston Scientific Announces Management Changes and Restructuring Initiatives
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 10 Feb 2010
SafeStitch Medical, Inc. Receives CE Mark for the AMID Hernia Stapler
Devices Surgery Regulatory

HSMN NewsFeed - 2 Feb 2010
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
Devices Monitoring Endocrinology Personnel

HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Jan 2010
EnteroMedics Announces Regulatory Path Forward Following FDA Meeting
Devices Gastroenterology FDA

HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 20 Jan 2010
Lantheus Medical Imaging, Inc. Launches ABLAVAR (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent
Biopharmaceuticals Radiology

HSMN NewsFeed - 19 Jan 2010
RCT and Zassi Medical Evolutions Form Leto Medical, LLC
Devices Gastroenterology Mergers & Acquisitions

HSMN NewsFeed - 18 Jan 2010
Covidien and Allergan Extend Agreement to Promote LAP-BAND(R) Adjustable Gastric Banding System
Devices Surgery Distribution

HSMN NewsFeed - 15 Jan 2010
FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Jan 2010
The Foundry Announces Completion of Series A Financing for Twelfth Company
Devices Venture Capital

HSMN NewsFeed - 11 Jan 2010
VIVUS Announces Additional Results of Phase 3 avanafil Study in Erectile Dysfunction Showing Efficacy in 15 Minutes
Biopharmaceuticals

HSMN NewsFeed - 11 Jan 2010
Novartis Launches Schizophrenia Treatment Fanapt in the US, Offering Patients an Attractive Alternative to Existing Medications
Biopharmaceuticals

HSMN NewsFeed - 7 Jan 2010
GI Dynamics Receives Strategic Investment from Medtronic, Inc.
Devices Gastroenterology Venture Capital

HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals

HSMN NewsFeed - 29 Dec 2009
VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Dec 2009
GI Dynamics Receives European CE Mark Approval for the EndoBarrier Gastrointestinal Liner System for the Treatment of Type 2 Diabetes and Obesity
Devices Gastroenterology Regulatory

HSMN NewsFeed - 21 Dec 2009
Dr. Julie Gerberding Named President of Merck Vaccines
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Dec 2009
Nasal-Aire(R) II Petite Receives FDA 510(k) Clearance for Pediatric Use
Devices FDA

HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Nov 2009
Diabetes Prevalence Expected to Double in Next 25 Years
Endocrinology Wound Care

HSMN NewsFeed - 23 Nov 2009
Four Senior Executives Join Orexigen(R) Therapeutics Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Nov 2009
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Nov 2009
VIVUS Announces Promotion of Peter Tam to President
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Nov 2009
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
Devices Endocrinology

HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Oct 2009
NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2009
Verathon(R) Helps Physicians Identify the Presence of Abdominal Aortic Aneurysms with New AortaScan(TM) Brand of Portable Ultrasound Aortic Measurement Instruments
Devices

HSMN NewsFeed - 29 Sep 2009
SafeStitch Medical, Inc. Appoints Dr. Chao Chen to Board of Directors
Devices Surgery Personnel

HSMN NewsFeed - 23 Sep 2009
Janssen-Cilag's STELARA(R) (Black Triangle Drug) (ustekinumab) Approved by NICE for the Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 14 Sep 2009
InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Sep 2009
Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Sep 2009
Salix Receives FDA Marketing Approval for METOZOLV ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 8 Sep 2009
ValenTx Completes $22 Million Series B Preferred Stock Financing
Devices Venture Capital

HSMN NewsFeed - 3 Sep 2009
OSI Pharmaceuticals Initiates Phase III Registration-Oriented Study for OSI-906 in Adrenocortical Carcinoma and Phase I/II Study in Ovarian Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Sep 2009
Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis' President, CEO & CSO
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Aug 2009
Ventana Enters Into a Multi Billion Dollar Market
Biopharmaceuticals

HSMN NewsFeed - 1 Aug 2009
New Data from Phase III SATURN Study Showed Tarceva Extended Survival in Patients with Advanced Non-Small Cell Lung Cancer When Used Immediately after Initial Chemotherapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Jul 2009
Embera NeuroTherapeutics Announces Expansion of Management Team after Successful Completion of Pilot Study of Cocaine Addiction Treatment
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jul 2009
Cutting Edge Obesity Surgery Successfully Completed With Power Medical Interventions'(r) Intelligent Surgical Instruments(tm)
Devices Surgery

HSMN NewsFeed - 13 Jul 2009
New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Jun 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Devices Surgery

HSMN NewsFeed - 7 May 2009
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
Biopharmaceuticals

HSMN NewsFeed - 5 May 2009
Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 23 Mar 2009
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Mar 2009
OSI Pharmaceuticals Files Patent Infringement Lawsuits Against Teva Pharmaceuticals USA and Mylan Pharmaceuticals
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 18 Mar 2009
OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Mar 2009
Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
Devices Monitoring

HSMN NewsFeed - 20 Feb 2009
Surgeons Perform First Incisionless Bariatric Procedure in the United States
Devices Surgery

HSMN NewsFeed - 19 Feb 2009
GI Dynamics Closes an Additional $15 Million in Series C Financing
Devices Venture Capital

HSMN NewsFeed - 17 Feb 2009
SafeStitch Medical, Inc. Announces FDA Approval to Market Its SMART Dilator(TM)
Devices Gastroenterology FDA

HSMN NewsFeed - 12 Feb 2009
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2009
Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 28 Jan 2009
VIVUS Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2009
Amylin Pharmaceuticals Appoints Vincent Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2009
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2008
Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2008
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Nov 2008
Tarceva(R) (erlotinib) Endorsed by the U.K.'s National Institute for Health and Clinical Excellence for Use in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Nov 2008
Akesis Pharmaceuticals Appoints Carl LeBel as CEO and Jay Lichter as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 23 Oct 2008
BAROnova Secures Investment From Allergan, Inc.
Devices Venture Capital

HSMN NewsFeed - 8 Oct 2008
Brennen Medical, LLC Launches XenMatriX(R) for Abdominal Wall (Hernia) Repair
Devices

HSMN NewsFeed - 2 Oct 2008
Apollo Endosurgery Announces 510(k) Clearance for Its Flexible Endoscopic Suturing System
Devices Surgery FDA

HSMN NewsFeed - 26 Sep 2008
GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier(TM) Gastrointestinal Liner for Pre-Surgical Weight Loss
Devices

HSMN NewsFeed - 25 Sep 2008
Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2008
EnteroMedics Announces Management Changes within the Clinical Department
Devices Personnel

HSMN NewsFeed - 15 Sep 2008
7 Health Ventures Invests in Tulip Medical
Devices Venture Capital

HSMN NewsFeed - 5 Sep 2008
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Sep 2008
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2008
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 22 Jul 2008
Response Biomedical Receives US FDA Clearance for RAMP(R) NT-proBNP Test for Diagnosis of Heart Failure
Diagnostics Cardiology FDA

HSMN NewsFeed - 9 Jul 2008
European Commission Announces Marketing Authorisation for 50mg Once Weekly Enbrel(R) for Patients With Moderate-to-Severe Psoriasis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 2 Jul 2008
Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
Devices Acquisitions

HSMN NewsFeed - 30 Jun 2008
Genaera Corporation Elects Paul K. Wotton to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2008
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2008
Tercica Announces Results from Increlex(R) IGFD Patient Registry and Other Increlex(R) Studies at the 90th Meeting of the Endocrine Society
Biopharmaceuticals

HSMN NewsFeed - 11 Jun 2008
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jun 2008
Sorin Group Announces Divestiture of Its Peripheral Stent Business to Datascope
Devices Interventional Acquisitions

HSMN NewsFeed - 10 Jun 2008
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2008
Cook Medical Announces FDA 510(k) Clearance of Evolution(R) Controlled Release Esophageal Stent System
Devices Interventional Oncology FDA

HSMN NewsFeed - 3 Jun 2008
Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
Diagnostics Cardiology

HSMN NewsFeed - 23 May 2008
New Evidence Advocates the use of Enbrel to Combat and Effectively Control the Debilitating Symptoms of Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 20 May 2008
GlycoVaxyn Appoints Philippe Dro as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 May 2008
Orexigen(R) Therapeutics Announces Completion of Patient Enrollment in Phase III Clinical Program for Contrave(R)
Biopharmaceuticals

HSMN NewsFeed - 6 May 2008
Apoptos Inc. Raises $28 Million in Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 6 May 2008
Tranzyme Pharma Strengthens Clinical Development Team With the Appointment of Philippa A. Charlton, MD, MPH as Medical Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2008
Dr. Reddy's Announces the Completion of Two Acquisitions
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 21 Apr 2008
VIVUS Appoints Charles J. Casamento to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Apr 2008
John D. Baxter, M.D. Joins Bionovo's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2008
VIVUS Enters into $30 Million Funding Collaboration for the Phase 3 Studies of Avanafil for Erectile Dysfunction
Biopharmaceuticals

HSMN NewsFeed - 3 Apr 2008
Dr. Reddy's Acquires Jet Generici Srl
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 1 Apr 2008
Dr. Reddy's Signs Definitive Agreement to Acquire Dowpharma Small Molecules Business Associated with Dow's Mirfield and Cambridge, UK Sites
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 31 Mar 2008
Phase III Data Showed Taranabant, Merck's Investigational Medicine to Treat Obesity, Led to Statistically Significant Weight Loss
Biopharmaceuticals

HSMN NewsFeed - 28 Mar 2008
New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients
Devices Endocrinology

HSMN NewsFeed - 25 Mar 2008
Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Mar 2008
enGene Inc. Completes US$6.4M Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Mar 2008
Data Presented at International Psoriasis Meeting Support Potential New Role for Biologic Treatment Etanercept in Management of Childhood Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 12 Mar 2008
Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2008
OREXIGEN(TM) Therapeutics Appoints Carol Baum as Vice President of Commercialization
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Mar 2008
Pfizer Presents New Opportunities for Global Growth
Biopharmaceuticals

HSMN NewsFeed - 12 Feb 2008
Sapphire Therapeutics Promotes Suzan Allen to Vice President Clinical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Feb 2008
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2008
Cook Medical Introduces Umbilical Hernia Graft Designed to Fit Individual Patient Anatomies
Devices

HSMN NewsFeed - 31 Jan 2008
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
Biopharmaceuticals

HSMN NewsFeed - 30 Jan 2008
Medical Ventures to Acquire Two Vascular Device Developers
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 28 Jan 2008
Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 23 Jan 2008
The American Association of Clinical Endocrinologists (AACE) Strongly Supports the FDA in Its Concerns Regarding the Marketing and Use of So-Called Bio-Identical Hormones
Biopharmaceuticals. FDA

HSMN NewsFeed - 23 Jan 2008
Aragon Surgical LapCap Receives FDA Special 510(k) Clearance for Use With Longer Needles Used in Morbidly Obese Patients
Devices Surgery FDA

HSMN NewsFeed - 21 Jan 2008
US Approval for SPP100 Combined with Diuretic to Treat Hypertension
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2008
New Study Shows Biologic Therapy Enbrel(R) (etanercept) Effective in Treating Psoriasis in Children and Adolescents
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2008
VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2008
EnteroMedics(TM) Announces Pivotal Clinical Study of its VBLOC(TM) Therapy for Obesity
Devices

HSMN NewsFeed - 7 Jan 2008
Genizon BioSciences Secures $31 Million in Additional Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Jan 2008
SYMLIN Pen-Injector Devices Now Available
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 7 Jan 2008
Nastech Appoints Bruce R. York as Interim Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2008
QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
Biopharmaceuticals

HSMN NewsFeed - 2 Jan 2008
Echo Therapeutics Starts Clinical Study of Its Symphony(TM) Continuous Transdermal Glucose Monitoring System
Devices Monitoring

HSMN NewsFeed - 21 Dec 2007
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
Biopharmaceuticals Radiology Distribution

HSMN NewsFeed - 20 Dec 2007
Nastech Announces Promotion of Gordon Brandt, M.D. to President
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2007
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 19 Dec 2007
Biogen Idec Announces First Startup in Its Innovation Incubator
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2007
Cyberonics Licenses Obesity-Related Patents
Devices Licensing

HSMN NewsFeed - 17 Dec 2007
CytRx Announces Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2007
EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures
Devices Surgery

HSMN NewsFeed - 14 Dec 2007
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 13 Dec 2007
BioMimetic Therapeutics Reports Positive Clinical Results for GEM OS(R)1 in Canadian Foot and Ankle Fusion Study
Devices Orthopaedic

HSMN NewsFeed - 13 Dec 2007
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2007
Lannett Receives FDA Approval for Phentermine
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 Dec 2007
VIVUS Initiates Third Qnexa Phase 3 Trial in Obese Patients
Biopharmaceuticals

HSMN NewsFeed - 11 Dec 2007
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 11 Dec 2007
OREXIGEN(TM) Therapeutics Initiates Fourth Phase III Trial for Contrave(TM) to Treat Obesity
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2007
Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 3 Dec 2007
FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Nov 2007
MetaCure(TM) Launches Investigational Study of Gastric Stimulator for Patients With Type 2 Diabetes Who are Overweight
Devices

HSMN NewsFeed - 16 Nov 2007
VIVUS Initiates Second Qnexa Pivotal Phase 3 Trial in Obese Patients
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2007
EnteroMedics Announces Initial Public Offering
Devices

HSMN NewsFeed - 13 Nov 2007
Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
Biopharmaceuticals

HSMN NewsFeed - 12 Nov 2007
Allergan, Inc. and Covidien Ltd. Enter into Co-Promotion Agreement for LAP-BAND(R) Adjustable Gastric Banding System
Devices

HSMN NewsFeed - 12 Nov 2007
Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Nov 2007
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2007
Neurochem announces important initiatives to provide medical and health benefits to patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Nov 2007
Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Nov 2007
Myomo Appoints Thomas Glover Chief Executive Officer
Devices Neurology Personnel

HSMN NewsFeed - 31 Oct 2007
Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 29 Oct 2007
Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Oct 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 25 Oct 2007
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2007
Liver Health Improves after Bariatric Surgery
Surgery

HSMN NewsFeed - 22 Oct 2007
Tarceva(R) (erlotinib) Earns Approval for Lung Cancer Patients in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Oct 2007
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 17 Oct 2007
Allergan Announces Completion of Esprit Pharma Acquisition
Biopharmaceuticals Urology Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2007
OREXIGEN(TM) Therapeutics Initiates its Third Phase III Trial for Contrave(TM) to Treat Obesity
Biopharmaceuticals

HSMN NewsFeed - 17 Oct 2007
Neurogen Corporation Announces Appointment of Kenneth J. Sprenger to Vice President, Clinical Development and Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Oct 2007
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 16 Oct 2007
Terumo Interventional Systems Launches New Radial Artery Compression Device
Devices Interventional

HSMN NewsFeed - 16 Oct 2007
CeNeRx BioPharma Adds Dr. Daniel Burch as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2007
OSI Pharmaceuticals Provides Additional Information about US Sales of Tarceva
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Oct 2007
Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
Diagnostics Cardiology

HSMN NewsFeed - 10 Oct 2007
Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
Biopharmaceuticals Cardiology

HSMN NewsFeed - 10 Oct 2007
Amarin Announces Initiation of Cardiovascular Development Strategy
Biopharmaceuticals

HSMN NewsFeed - 8 Oct 2007
Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing
Devices Surgery Venture Capital

HSMN NewsFeed - 4 Oct 2007
Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
Biopharmaceuticals Personnel Drug Delivery

HSMN NewsFeed - 3 Oct 2007
Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Oct 2007
Metabasis Announces European Commission Grants Orphan Medicinal Product Designation to MB07133, Its Product Candidate for the Treatment of Primary Liver Cancer
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Oct 2007
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 1 Oct 2007
Synvista Therapeutics Appoints Carl M. Mendel, M.D. Vice president, Clinical Development and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2007
FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
Devices Drug Delivery Endocrinology FDA

HSMN NewsFeed - 28 Sep 2007
FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
Devices Surgery FDA

HSMN NewsFeed - 26 Sep 2007
Palatin Technologies Announces Reduction of Workforce
Biopharmaceuticals

Return to NewsFeed

Additional items found! 463

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 463 additional stories matching:
obesity
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.